Trial · NCT00764868
Adverse events21
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 21
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dry Mouth | Gastrointestinal disorders | Lisdexamfetamine Dimesylate (LDX) | 14 | 265 | 15 |
| other | Irritability | General disorders | Lisdexamfetamine Dimesylate (LDX) | 33 | 265 | 36 |
| other | Influenza | Infections and infestations | Lisdexamfetamine Dimesylate (LDX) | 18 | 265 | 18 |
| other | Nasopharyngitis | Infections and infestations | Lisdexamfetamine Dimesylate (LDX) | 19 | 265 | 26 |
| other | Upper Respiratory Tract Infection | Infections and infestations | Lisdexamfetamine Dimesylate (LDX) | 58 | 265 | 74 |
| other | Weight Decreased | Investigations | Lisdexamfetamine Dimesylate (LDX) | 43 | 265 | 46 |
| other | Decreased Appetite | Metabolism and nutrition disorders | Lisdexamfetamine Dimesylate (LDX) | 56 | 265 | 71 |
| other | Dizziness | Nervous system disorders | Lisdexamfetamine Dimesylate (LDX) | 14 | 265 | 16 |
| other | Headache | Nervous system disorders | Lisdexamfetamine Dimesylate (LDX) | 55 | 265 | 81 |
| other | Insomnia | Psychiatric disorders | Lisdexamfetamine Dimesylate (LDX) | 32 | 265 | 43 |
| serious | Hydrocele | Congenital, familial and genetic disorders | Lisdexamfetamine Dimesylate (LDX) | 1 | 265 | 1 |
| serious | Pneumonia | Infections and infestations | Lisdexamfetamine Dimesylate (LDX) | 1 | 265 | 1 |
| serious | Joint Sprain | Injury, poisoning and procedural complications | Lisdexamfetamine Dimesylate (LDX) | 1 | 265 | 1 |
| serious | Pelvic Fracture | Injury, poisoning and procedural complications | Lisdexamfetamine Dimesylate (LDX) | 1 | 265 | 1 |
| serious | Traumatic Liver Injury | Injury, poisoning and procedural complications | Lisdexamfetamine Dimesylate (LDX) | 1 | 265 | 1 |
| serious | Wrist Fracture | Injury, poisoning and procedural complications | Lisdexamfetamine Dimesylate (LDX) | 1 | 265 | 1 |
| serious | Syncope | Nervous system disorders | Lisdexamfetamine Dimesylate (LDX) | 3 | 265 | 4 |
| serious | Syncope Vasovagal | Nervous system disorders | Lisdexamfetamine Dimesylate (LDX) | 1 | 265 | 1 |
| serious | Ectopic Pregnancy | Pregnancy, puerperium and perinatal conditions | Lisdexamfetamine Dimesylate (LDX) | 1 | 265 | 1 |
| serious | Aggression | Psychiatric disorders | Lisdexamfetamine Dimesylate (LDX) | 2 | 265 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00764868/events